Specialty Pharma Journal Specialty, Precision & Technology
BINGHAMTON, NY – A new paper, co-written by faculty at Binghamton University, State University of New York, increases the understanding of Duchenne muscular dystrophy (DMD)–one of the most common lethal genetic disorders–and points to potential therapeutic approaches. “The findings suggest that the immune system has an important role in the …
Tag Archives: muscular dystrophy
October, 2016
April, 2015
-
9 April
TGen Uses Personalized Medicine to Discover Genetic Source of Muscle Weakness in Children
State-of-the-art genetic technology has allowed scientists at the Translational Genomics Research Institute (TGen) to discover the likely cause of a child’s rare type of severe muscle weakness. The child was one of six cases that TGen sequenced, or decoded, the genes of patients with Neuromuscular Disease (NMD) and was then …